US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on July 14 for "2-(3-ethynylbenzyl)-substituted heterocycle derivatives and related uses" (British, American Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,804, issued on July 14, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain).

"2-(3-ethynylbenzyl)-substituted heterocycle derivatives and related uses" was invented by John Andrew Christopher (Cambridge, Great Britain), Karl Gibson (Sandwich, Great Britain), Paul Humphries (Santa Clara, Calif.), Gordon Saxty (Cambridge, Great Britain), Matthew Spendiff (Cambridge, Great Britain) and Wojciech Zawodny (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds of Formula (I):and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods ...